May 2006
Volume 47, Issue 13
Jump To...
Free
ARVO Annual Meeting Abstract  |   May 2006
Effects of Intraocular Injections of Antibody to Vascular Endothelial Growth Factor Isoform 164 on Oxygen–Induced Retinopathy in Neonatal Rats
Y. Saito; D.J. Martiniuk; P. Geisen; W. Smith; L.J. Peterson; J.R. McColm; M.E. Hartnett
Author Affiliations & Notes
  • Y. Saito
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • D.J. Martiniuk
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • P. Geisen
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • W. Smith
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • L.J. Peterson
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • J.R. McColm
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • M.E. Hartnett
    Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • Footnotes
    Commercial Relationships  Y. Saito, None; D.J. Martiniuk, None; P. Geisen, None; W. Smith, None; L.J. Peterson, None; J.R. McColm, None; M.E. Hartnett, None.
  • Footnotes
    Support  NIH R01 Grant EY015130–01A1; Retina Research Foundation Mills and Margaret Cox Endowment Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5316. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Effects of Intraocular Injections of Antibody to Vascular Endothelial Growth Factor Isoform 164 on Oxygen–Induced Retinopathy in Neonatal Rats
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Y. Saito, D.J. Martiniuk, P. Geisen, W. Smith, L.J. Peterson, J.R. McColm, M.E. Hartnett; Effects of Intraocular Injections of Antibody to Vascular Endothelial Growth Factor Isoform 164 on Oxygen–Induced Retinopathy in Neonatal Rats . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5316.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract
 
Purpose:
 

To investigate intraocular injections of antibody to VEGF164 on oxygen–induced retinopathy (OIR) in rats.

 
Methods:
 

Newborn rat pups were exposed to cycles of 24 h of 50% oxygen and 24 h of 10% oxygen. On p12 pups were randomly assigned to receive intraocular injections in their right eyes of either 25ng, 50ng, 100ng VEGF164 antibody (R&D Systems, MN) or PBS. The matched left eyes were non–injected. Animals were returned to the Oxycycler (Biospherix, NY) until p14 and then moved to room air until p18 when they were weighed and sacrificed. Retinas were dissected, flat mounted and stained with lectin. Clock hours of neovascularization (NV) were counted and avascular areas were expressed as a percent of total retinal area. Junctions of capillaries were counted as a measure of central capillary density. Data was analyzed using SPSS software.

 
Results:
 

There were two separate litters and body weights were not significantly different between them, or between pups, at p14 or p18. There were significant differences between treatment groups for clock hours and central capillary density (NV, ANOVA p=0.046; capillary density, ANOVA p=0.043). Total retinal areas and peripheral avascular areas were not significantly different between groups.

 
Conclusions:
 

Intraocular injections of antibody to VEGF164 prevented pathological retinal neovascularization and reduced central capillary density. The total retinal areas and peripheral avascular areas were not affected. These data confirm that VEGF164 is an important promoter of intravitreous retinal neovascularization.  

Image not available
View OriginalDownload Slide
Image not available
View OriginalDownload Slide

 
Keywords: retinal neovascularization • proliferative vitreoretinopathy • drug toxicity/drug effects 
© 2006, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept